Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EFTRENONACOG ALFA vs ELACESTRANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EFTRENONACOG ALFA vs ELACESTRANT: Safety Overview

Metric EFTRENONACOG ALFA ELACESTRANT
Total FAERS Reports 2,138 6,935
Deaths Reported 29 525
Death Rate 1.4% 7.6%
Hospitalizations 379 843
Average Patient Age 26.7 yrs 65.7 yrs
% Female Patients 2.0% 99.1%
FDA Approval Date N/A Jan 27, 2023
Manufacturer N/A Stemline Therapeutics, Inc.
Route N/A ORAL
Marketing Status N/A Prescription